Novo Nordisk Logo JPEG

Novo Nordisk hits all-time high as oral obesity...

Novo Nordisk Logo Png

Novo Nordisk receives FDA approval for Wegovy™

Novo Nordisk launches once-a-week diabetes drug...

Novo Nordisk to test anti-obesity molecule in t...

Novartis' Sandoz dips on debut after lower than...

Novo Nordisk’s Global Commitment to Diabetes Ca...

Novo Nordisk experience big profit rise due to ...

Novo Nordisk

Signal: Novo Nordisk market cap higher than Dan...

Novo Nordisk - la compañia que trata la diabete...

Novo Nordisk A/S Sees Unusually Large Options V...

Novo Nordisk amplía sus fármacos contra la obes...

China OKs Novo Nordisk's Type-2 diabetes treatm...

Novo Nordisk Logo Png

Novo Nordisk's results are stunning - and it co...

Novo Nordisk Posts Record Growth as Demand For ...

Novo Nordisk leaps on new obesity drug data | p...

First: Novo Nordisk India launches oral Semaglu...

FID prosigue su larga colaboración con Novo Nor...

NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...

Is Novo Nordisk Stock a Buy After its Collapse?...

Novo Nordisk submits diabetes pill for US approval

Novo Nordisk

Novo Nordisk Research Centre opens in Oxford | ...